These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5215763)

  • 1. Complement-fixing antibrain antibodies and allergic encephalomyelitis. II. Further studies concerning their protective role.
    Paterson PY; Jacobs AF; Coia EM
    Ann N Y Acad Sci; 1965 Jun; 124(1):292-8. PubMed ID: 5215763
    [No Abstract]   [Full Text] [Related]  

  • 2. COMPLEMENT-FIXING ANTIBRAIN ANTIBODIES AND ALLERGIC ENCEPHALOMYELITIS. I. CHARACTERIZATION OF THE ANTIBODIES.
    PATERSON PY; COIA EM; JACOBS AF
    Ann N Y Acad Sci; 1965 Mar; 122():256-65. PubMed ID: 14313483
    [No Abstract]   [Full Text] [Related]  

  • 3. The temporal relationship of complement-fixing antibrain and tuberculin type sensitivity in experimental allergic encephalomyelitis.
    Greifenkamp J; Bartel AH; Fahlberg WJ
    Ann Allergy; 1970 Nov; 28(11):522-7. PubMed ID: 5521183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoluminescent study of the sera of guinea pigs with experimental allergic encephalomyelitis].
    Zhitnukhin IuL; Zubzhitskiĭ IuN
    Biull Eksp Biol Med; 1972 Aug; 73(8):63-5. PubMed ID: 4564367
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of allergic encephalomyelitis in rats by means of antibrain serum.
    PATERSON PY; HARWIN SM
    J Exp Med; 1963 May; 117(5):755-74. PubMed ID: 13941827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
    Hughes RA; Leibowitz S
    Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dyamics of the clinico-immunologic and histopathologic changes in the development of experimental allergic encephalomyelitis].
    Savenko SN; Tauber IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(2):171-5. PubMed ID: 4173467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of serum antibodies in the pathogenesis of experimental pertussis encephalomyelitis].
    Kanchurin AKh; Zotina MM
    Patol Fiziol Eksp Ter; 1970; 14(4):12-6. PubMed ID: 4323829
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY; Drobish DG; Hanson MA; Jacobs AF
    Int Arch Allergy Appl Immunol; 1970; 37(1):26-40. PubMed ID: 5410772
    [No Abstract]   [Full Text] [Related]  

  • 10. The susceptibility of rat strains to experimental allergic encephalomyelitis.
    Hughes RA; Stedronska J
    Immunology; 1973 May; 24(5):879-84. PubMed ID: 4715260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of chronic experimental allergic encephalomyelitis (immunologic and electron microscopic studies)].
    Davydova GS; Pashkovskaia MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(7):994-1002. PubMed ID: 4777970
    [No Abstract]   [Full Text] [Related]  

  • 12. Passive transfer of "allergic" encephalomyelitis with antibrain serum injected into the lateral ventricle of the brain.
    Janković BD; Draskoci M; Jancić M
    Nature; 1965 Jul; 207(995):428-9. PubMed ID: 4957348
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE SEROLOGY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. I. COMPARISON OF REACTIVITY OF LIPID MIXTURES AND MYELIN EXTRACTS WITH CORRESPONDENT ANTISERA IN PRECIPITATION TESTS AND IN THE COMPLEMENT FIXATION REACTION].
    NIEDIECK B; KUWERT E
    Z Immunitats Allergieforsch; 1963 Dec; 125():470-92. PubMed ID: 14123283
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord.
    Hughes RA
    Immunology; 1974 Apr; 26(4):703-11. PubMed ID: 4212280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathogenesis of experimental allergic encephalomyelitis and neuritis in nerve tissue cultures (review of the literature)].
    Kamzolkina NB; Kanchurin AKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):289-94. PubMed ID: 4986495
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the pathogenesis of organic and systemic disorders in trichinosis. II. Experimental trichinous allergic encephalomyelitis].
    Ozeretskovskaia NN; Vikhert AM; Frol'tsova AE; Konovalova LM
    Med Parazitol (Mosk); 1966; 35(4):395-402. PubMed ID: 5993825
    [No Abstract]   [Full Text] [Related]  

  • 18. CHEMICAL AND IMMUNOCHEMICAL STUDIES WITH A DIALYZABLE ENCEPHALITOGENIC COMPOUND FROM BOVINE SPINAL CORD.
    NAKAO A; ROBOZ-EINSTEIN E
    Ann N Y Acad Sci; 1965 Mar; 122():171-81. PubMed ID: 14313477
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis of experimental allergic encephalomyelitis].
    Iarosh AA; Korchemnyĭ VA
    Vrach Delo; 1985 Apr; (4):94-5. PubMed ID: 4013205
    [No Abstract]   [Full Text] [Related]  

  • 20. The problem of circulating antibrain antibodies in experimental allergic encephalomyelitis.
    Saragea M; Vlăduţiu A; Rotaru N; Negru T
    Acta Allergol; 1966; 21(2):139-54. PubMed ID: 5953556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.